Table 1.
Patient Characteristics
| Control Subjects | ED Subjects | P Value | |
|---|---|---|---|
| Number | 33 | 47 | |
| Age, yrs | 51.0 ±* 10.3 | 52.2 ± 10 | 0.60 |
| BMI, kg/m2 | 28.4 ± 5.7 | 29.0 ± 6.5 | 0.57 |
| Female, n (%) | 24 (73%) | 31 (66%) | 0.63 |
| Hypertension, n (%) | 15 (45%) | 22 (47%) | 0.99 |
| Diabetes, n (%) | 3 (9%) | 3 (6%) | 0.98 |
| Hypercholesterolemia, n (%) | 18 (55%) | 25 (53%) | 1.00 |
| Smoking (current), n (%) | 3 (9%) | 8 (17%) | 0.51 |
| Smoking (previous), n (%) | 14 (42%) | 15 (32%) | 0.36 |
| Aspirin use, n (%) | 17 (52%) | 26 (55%) | 0.82 |
| Statin use, n (%) | 12 (36%) | 24 (51%) | 0.25 |
| Cholesterol, mg/dL | 200 ± 37 | 182 ± 53 | 0.09 |
| Triglycerides, mg/dL | 180 ± 203 | 131 ± 83 | 0.14 |
| HDL-C, mg/dL | 61 ± 22 | 53 ± 15 | 0.052 |
| LDL-C, mg/dL | 108 ± 33 | 103 ± 43 | 0.64 |
| Hs-CRP, mg/L | 1.8 ± 2.6 | 1.8 ± 3.0 | 0.95 |
| Homocystine, μmol/L | 10.3 ± 11.6 | 7.8 ± 2.2 | 0.17 |
| Brain natriuretic peptide, pg/mL | 91 ± 95 | 101 ± 120 | 0.73 |
| Lipoprotein(a), mg/dL | 25 ± 31 | 22 ± 29 | 0.62 |
*
+/−, standard deviation